Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Leeds academic presents a seminar on racism in the UK
2014-07-30

 


Dr Shirley Tate during her seminar on colour-blind racism.
Photo: O'Ryan Heideman

A prominent researcher and academic, Dr Shirley Tate, recently delivered an academic paper – soon to be published – on racism at institutions of higher learning in the United Kingdom. The seminar was hosted at the Bloemfontein and Qwaqwa Campus by the Institute for Reconciliation and Social Justice.

Dr Tate spoke about colour-blind racism – where racism at an interpersonal level, racial differences and ethnic particularities are overlooked. Colour-blind racism continues to negate the fact that skin colour has consequences in societies where it has been claimed that 'race' no longer matters.

Dr Tate, author of two books, is particularly interested in exploring the intersections of 'raced' and gendered bodies, race performativity, critical mixed race and racism in organisations.

Her talk sparked a lot of interest from both students and staff who were extremely keen to find out more about her extensive research and its striking similarities to our South African experience.

Dr Tate is an Associate Professor in Race and Culture and Director of the Centre for Ethnicity and Racism Studies at the University of Leeds in the United Kingdom.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept